ETFIQData as of Nov 18, 2026. · etfiq.com/funds/rsph

RSPH Fact Sheet: Invesco S&P 500 Equal Weight Health Care ETF

Share
$39.91
close, Nov 18, 2026

Over the year to Nov 18, 2026, RSPH returned +29.7% in total and charged 0.40% a year.

1-year total return
+29.7%
to Nov 18, 2026
Expense ratio
0.40%
a year
Net assets
$1.0bn
on Nov 17, 2026
Net flow, last 5 trading days
+$17.7m
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

RSPH $12,972 +29.7% · IVV $11,186 +11.9% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+3.2%
3 months+5.1%
Year to date+26.0%
1 year+29.7%
3 years+51.7%
5 years+35.9%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Moderna Inc2.29%
IDEXX Laboratories Inc2.02%
Mettler-Toledo International Inc2.00%
GE HealthCare Technologies Inc1.88%
Eli Lilly & Co1.88%
Viatris Inc1.86%
West Pharmaceutical Services Inc1.84%
McKesson Corp1.84%
Edwards Lifesciences Corp1.83%
Intuitive Surgical Inc1.83%

RSPH top ten by weight, 19.3% of the fund, of its 63 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P 500 Equal Weight Health Care Index · First traded Nov 7, 2006 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, RSPH Fact Sheet: Invesco S&P 500 Equal Weight Health Care ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/rsph/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/rsph.